Why the study?
Do EEG-based biomarkers allow distinguishing between MDD patients and healthy controls and predict treatment response?
Do EEG-based biomarkers allow distinguishing between MDD patients and healthy controls and predict treatment response?
EEG-based biomarkers hold promise for diagnosing MDD and predicting treatment response, but standardization is required for future clinical application.
No takes yet. Share an insight, caveat, or question.
EEG biomarkers remain investigational for MDD diagnosis and prognosis; leaves open their utility pending standardized prospective validation.
Olbrich et al. (2013) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: